Grown Rogue Industries
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
At a composite of 35, Grown Rogue International scores as Neutral, with conviction of 3 out of 5 backing the assessment. The composite is a fixed blend of four pillars — fundamentals at 35 percent, regulatory at 25, market at 25, and editorial at 15 — and each contribution is inspectable. The strongest contribution comes from the regulatory pillar at 53, and pulls the composite toward the lower edge of the band. Fundamentals lags at 22, softening what would otherwise be a stronger reading.
Working through the numbers, Grown Rogue International shows reported revenue growth of -19.5 percent year over year, an operating margin of -119.2 percent, a filing cadence of 1 regulator events in the trailing 90 days. Those inputs are the ones that drive the Neutral anchor rather than sentiment. Every input flowing into the pillar table comes from primary regulatory filings, licensed fundamentals data, and institutional pricing feeds, filtered through CIN newsroom density. The 336-ticker CIN universe is scored deterministically, so Grown Rogue International can be compared against the US operator peer set on identical inputs, refreshed on the ingest cycle.
The rating turns on regulatory pace. Filings landing at above the trailing-90-day cadence, combined with an unblemished enforcement record, would carry Grown Rogue International above the Neutral anchor; a lull would soften the read.
- IR email
- info@grownrogue.com
- SEC CIK
- 0001876945
- Website
- Company website
- Market cap
- $20.1M
- Enterprise value
- $3.5M
- Price to book
- 0.11
- Price to sales
- 0.14
- EV / EBITDA
- 0.08
- Revenue (TTM)
- $79.3M
- Gross profit (TTM)
- $20.2M
- EBITDA
- $-71.9M
- Operating margin
- -119.2%
- Profit margin
- -284.5%
- Rev growth YoY
- -19.5%
- Return on equity
- -85.2%
- Return on assets
- -14.9%
- EPS (TTM)
- $-2.03
- EPS est. current year
- $-0.60
- Wall St. target price
- $0.39
- Shares outstanding
- 118.8M
- Insider ownership
- 27.4%
- Institutional ownership
- 0.5%
- Beta
- 0.94
- Full-time employees
- 267
- GICS sector
- Healthcare
- GICS industry
- Drug Manufacturers - Specialty & Generic
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for Grown Rogue Industries (GRAMF)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Grown Rogue Industries (GRAMF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for GRAMF are maintained by Cannabis Investor News and refreshed throughout the trading day.